Retatrutide Surpasses Ozempic in Weight Loss During Phase 3 Trial | Retatrutide News

Retatrutide has shown to double the weight loss achieved by Ozempic in a Phase 3 trial. This marks a significant development in GLP-1 agonist research a...
Clinical Trials · November 1, 2026